Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TRA | Ann: D& O Ongoing Disclosure Notice - Alistair Petrie | 08:05 | 0 | 41 | |||
|
|||||||
TRA | Ann: DRP Capital Change Notice | 29/07/25 | 0 | 42 | |||
|
|||||||
TRA | Ann: Turners 2025 Climate Related Disclosures | 23/07/25 | 0 | 74 | |||
|
|||||||
TRA | Ann: Dividend Reinvestment Plan Strike Price | 18/07/25 | 0 | 108 | |||
|
|||||||
TRA | Ann: Turners Annual Meeting | 18/07/25 | 0 | 98 | |||
|
|||||||
TRA | Ann: Turners FY25 Annual Report | 24/06/25 | 0 | 76 | |||
|
|||||||
TRA | Ann: Director Nominations | 05/06/25 | 0 | 84 | |||
|
|||||||
TRA | Ann: Turners - Exercise of share options | 28/05/25 | 0 | 88 | |||
|
See All Discussions